Respiratory syncytial virus infection – Life with Disease

Go back

Respiratory syncytial virus infection, commonly known as RSV, is a widespread respiratory illness that affects people of all ages, though it poses the greatest danger to babies, older adults, and those with weakened immune systems or underlying health conditions.

Prognosis and What to Expect

For most people who catch respiratory syncytial virus, the outlook is generally positive and reassuring. The vast majority of children and adults experience RSV as nothing more than an uncomfortable cold that resolves on its own within one to two weeks.[1] This means that most individuals recover completely without any lasting health problems, returning to their normal activities as their symptoms gradually fade away.

However, the prognosis becomes more serious for certain groups of people. Infants, particularly those younger than six months, face a higher risk of developing severe complications. Almost all children will have been infected with RSV at least once by their second birthday, and many will experience it twice during their first two years of life.[2] While this widespread exposure shows how common the virus is, it also highlights why young babies are especially vulnerable during their first encounter with RSV.

In the United States, approximately two to three out of every 100 infants with RSV infection require hospitalization.[2] These admissions typically last only a few days, during which babies receive supportive care such as oxygen therapy or intravenous fluids to stay hydrated. The good news is that most hospitalized infants recover and return home without long-term complications. Nevertheless, it’s important to understand that about 80 percent of children younger than two years old who are hospitalized with RSV do not have previously identified risk factors, meaning even seemingly healthy babies can become seriously ill.[3]

For older adults, particularly those aged 65 and above, RSV can also lead to serious illness. Each year in the United States, RSV causes an estimated 100,000 to 160,000 hospitalizations among adults in this age group.[3] Adults with chronic heart or lung disease, diabetes, obesity, or weakened immune systems face an elevated risk of severe disease if they contract RSV.

The mortality rate from RSV is generally low in the overall population, remaining below one percent. However, patients with chronic respiratory disease, heart disease, or compromised immune systems face a mortality risk of three to five percent.[13] Historical data from the Centers for Disease Control and Prevention suggests that approximately 200 to 500 children die annually in the United States from RSV-associated illnesses.[13]

⚠️ Important
While most people recover from RSV without complications, certain warning signs require immediate medical attention. These include severe difficulty breathing, bluish or grayish skin color, pauses in breathing, nostrils flaring with each breath, or skin pulling inward between the ribs when breathing. If you or your child experiences any of these symptoms, seek emergency medical care right away.

Natural Progression of the Disease

Understanding how RSV typically develops helps families know what to expect if someone in their household becomes infected. The virus enters the body through the nose or eyes, usually after contact with infected saliva, mucus, or nasal discharge from an infected person.[13] The illness doesn’t appear immediately—symptoms usually begin to show about four to six days after exposure to the virus.[1]

When symptoms do emerge, they tend to appear gradually over several days rather than all at once. In adults and older children, RSV typically starts with mild, cold-like symptoms including a congested or runny nose, dry cough, low-grade fever, sore throat, sneezing, and headache.[1] These symptoms mirror those of many common colds, which is why RSV often goes unrecognized in otherwise healthy adults.

For babies and very young children, the progression can look somewhat different. In very young infants, the only symptoms might be irritability, decreased activity, and breathing difficulties, without the typical cold symptoms adults experience.[4] Young babies might also feed poorly, appearing fussier than usual or less interested in eating.

Most people remain contagious—meaning they can spread the virus to others—for about three to eight days while symptoms are present.[4] Interestingly, individuals may become contagious a day or two before symptoms even begin, which is part of why RSV spreads so easily through families and childcare settings. For some infants and people with weakened immune systems, the contagious period can extend much longer, up to four weeks, even after symptoms have improved.[4]

In cases where the infection worsens, RSV can spread deeper into the respiratory system, affecting the lower respiratory tract. This progression can lead to more serious conditions such as bronchiolitis (inflammation of the small airways in the lungs) or pneumonia (infection of the lung tissue itself). When this happens, symptoms become more severe and may include fever, a worsening cough, wheezing (a high-pitched whistling sound when breathing out), rapid or difficult breathing, and in serious cases, a bluish discoloration of the skin due to insufficient oxygen.[1]

Symptoms, particularly the cough, may persist for several days to several weeks even after the acute infection has resolved.[6] This lingering cough can be frustrating for patients and families, but it’s a normal part of recovery for many people with RSV.

Possible Complications

While most RSV infections resolve without incident, complications can and do occur, particularly in vulnerable populations. The most common serious complications involve the respiratory system, where inflammation and infection can make breathing increasingly difficult.

Bronchiolitis represents one of the most frequent complications of RSV, especially in infants and young children. This condition involves inflammation and swelling of the small airways called bronchioles, which carry air into the lungs. RSV is the leading cause of bronchiolitis in children younger than one year of age.[2] When the bronchioles become inflamed, they narrow and fill with mucus, making it harder for air to flow in and out of the lungs. This results in the characteristic wheezing sound and difficulty breathing that often prompts parents to seek medical care.

Pneumonia, an infection of the lung tissue itself, is another serious complication that can develop from RSV. Unlike bronchiolitis, which affects the airways, pneumonia involves inflammation and fluid accumulation in the air sacs of the lungs. RSV is also a common cause of pneumonia in young children and can lead to severe respiratory problems in older adults.[2] Pneumonia may develop as the initial RSV infection worsens or can occur as a secondary bacterial infection that takes hold while the immune system is fighting the virus.

For people with pre-existing health conditions, RSV can cause their underlying diseases to worsen significantly. Individuals with asthma may experience severe flare-ups triggered by the viral infection. Those with congestive heart failure (a condition where the heart doesn’t pump blood as efficiently as it should) or chronic obstructive pulmonary disease (COPD) (a group of lung diseases that make breathing difficult) may find their symptoms dramatically worsening during an RSV infection.[5]

In severe cases, RSV can lead to respiratory failure, a life-threatening condition where the lungs cannot provide enough oxygen to the body or remove enough carbon dioxide. When this happens, patients may require mechanical ventilation, where a machine helps them breathe. Related to this is hypoxia, a state where body tissues don’t receive adequate oxygen, which can cause the skin, lips, and nail beds to appear bluish or grayish.[5]

Dehydration is another common complication, particularly in babies and young children. When infants are struggling to breathe, they often feed poorly or refuse to eat entirely. Combined with fever and increased respiratory effort, this can quickly lead to fluid loss. Signs of dehydration include decreased urination (dry diapers for 12 hours or more in babies), sunken eyes, and extreme fussiness or sleepiness.[9]

Ear infections can also develop as a complication of RSV. The virus can cause inflammation and fluid buildup in the middle ear, leading to pain and potentially requiring antibiotic treatment if a bacterial infection develops.[5]

Impact on Daily Life

An RSV infection, even when it doesn’t require hospitalization, can significantly disrupt normal daily life for patients and their families. The impact varies depending on the severity of symptoms and the age of the person infected, but the ripple effects often extend well beyond the individual patient.

For families with young children, an RSV infection typically means keeping the sick child home from daycare or preschool for at least a week, and often longer if the cough persists. This creates immediate practical challenges for working parents who must arrange childcare or take time off from work. Given that children can remain contagious for three to eight days (and sometimes much longer), this period of isolation can feel quite extended.[4] The virus spreads easily within households, so it’s not uncommon for multiple family members to become ill in succession, further prolonging the disruption to family routines.

Physically, even a mild case of RSV can be exhausting. The constant coughing, nasal congestion, and fever leave patients feeling tired and uncomfortable. Babies may become extremely fussy and irritable, crying more than usual and resisting comfort. Poor feeding in infants is particularly concerning and stressful for parents, who worry about their baby getting enough nutrition and fluids. The combination of sleep disruption from nighttime coughing and the effort required for breathing means that both sick children and their caregivers often experience significant sleep deprivation.

For older adults living independently, RSV can temporarily rob them of their self-sufficiency. Even routine activities like preparing meals, bathing, or walking around the house may become difficult when someone is short of breath or extremely fatigued. This may necessitate asking for help from family members or neighbors, which can be emotionally difficult for seniors who value their independence.

Emotionally, dealing with RSV can be frightening, especially for first-time parents watching their infant struggle to breathe. The wheezing sounds, rapid breathing, and visible effort required for each breath can be alarming. Parents often experience significant anxiety about whether their child needs emergency care or hospitalization, and this worry can persist even after symptoms begin to improve.

The financial impact can also be substantial. Hospital stays, emergency room visits, and multiple doctor’s appointments add up quickly. Even without hospitalization, there are costs for medications, lost wages from missed work, and potentially the need to hire additional childcare help. For families without adequate health insurance, these expenses can create significant financial stress.

Social isolation is another consequence of RSV infection. To prevent spreading the virus to others, families often cancel social plans, miss family gatherings, and avoid public places. This isolation can feel particularly difficult during holiday seasons when RSV typically peaks. Children miss birthday parties and playdates, while adults may need to skip important work events or social commitments.

For those who do require hospitalization, the impact intensifies dramatically. Being in the hospital separates families, as parents may need to take turns staying with a hospitalized child while managing work and caring for other children at home. The hospital environment itself can be stressful, with unfamiliar medical equipment, frequent interruptions for monitoring and treatments, and the general anxiety that comes with serious illness.

Fortunately, there are strategies that can help families cope with these challenges. Maintaining good hydration is crucial—offering frequent small amounts of fluids, even if the person doesn’t feel like drinking, helps prevent dehydration. Using a cool-mist humidifier can ease breathing difficulties and soothe irritated airways. Elevating the head during sleep (safely, for older children and adults) can help reduce congestion and coughing. For babies, frequent gentle suctioning of the nose with a bulb syringe before feedings can make eating easier.[10]

Creating a calm, comfortable environment helps manage the stress. This might mean simplifying daily routines, letting household chores slide temporarily, and focusing energy on rest and recovery. Accepting help from friends and family with tasks like meal preparation or caring for other children can provide much-needed relief.

Support for Family in Clinical Trials

Clinical trials represent an important avenue for advancing medical knowledge about RSV and developing new ways to prevent and treat the infection. For families considering whether to participate in RSV-related clinical trials, understanding what these studies involve and how they might help can be valuable.

Clinical trials for RSV typically focus on testing new preventive measures, such as vaccines or antibody treatments, or on evaluating potential antiviral medications that might reduce the severity or duration of illness. These studies are carefully designed to answer specific scientific questions while protecting the safety of participants. Before any clinical trial can begin enrolling patients, it must be reviewed and approved by institutional review boards that ensure the study is ethically sound and that risks to participants are minimized.

Families should know that participating in a clinical trial is always voluntary. No one is ever obligated to join a study, and participants have the right to withdraw at any time without affecting their regular medical care. Before enrolling, researchers are required to explain the study thoroughly in a process called informed consent, which includes discussing the potential benefits, risks, what procedures will be involved, and how personal information will be protected.

When considering whether a family member should participate in an RSV clinical trial, relatives can provide important support in several ways. First, they can help gather and organize medical records and information about the person’s health history, as trials often have specific criteria about who can participate. Understanding whether someone is eligible before investing time in the screening process can save everyone effort.

Family members can accompany their loved one to appointments where the clinical trial is explained, providing an extra set of ears to hear information and ask questions. It’s helpful to write down questions ahead of time about things like how often study visits will occur, what procedures will be done, whether there are any costs to participate, and what happens if the person becomes ill during the study.

For trials involving infants or young children, parents and family members play an especially crucial role in observing and reporting any changes in symptoms or behavior. Researchers rely on this information to monitor safety and effectiveness. Keeping a simple diary of symptoms, medications given, and any concerns that arise can be tremendously helpful.

Practical support matters too. Clinical trials often require more frequent visits to medical centers than routine care would involve. Family members can help by providing transportation, arranging childcare for siblings during study visits, or adjusting work schedules to accommodate appointment times. Understanding the time commitment involved upfront helps families plan accordingly.

It’s also important for families to understand that not everyone in a clinical trial receives the experimental treatment. Many studies use a control group that receives either a placebo (an inactive substance) or the current standard treatment, so that researchers can compare outcomes fairly. This is explained during the informed consent process, and families should feel comfortable asking how this works in any particular study.

Finally, family members can help their loved one feel supported emotionally throughout the trial. Participating in research can feel uncertain or anxiety-provoking, especially when dealing with a potentially serious illness like RSV in an infant. Encouragement, reassurance, and simply being present during the process provides invaluable emotional support.

Families interested in learning about RSV clinical trials can talk to their healthcare provider, who may know about studies recruiting patients locally. Major medical centers and children’s hospitals often conduct clinical trials and can provide information about current opportunities. Online databases of clinical trials are also available where families can search for studies related to RSV.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Ribavirin (aerosolized) – A broad-spectrum antiviral agent licensed by the FDA for aerosolized treatment of children with severe RSV disease, though its use is limited due to high cost and lack of demonstrated benefit in decreasing hospitalization or mortality.
  • Palivizumab – A monoclonal antibody used for RSV prophylaxis in high-risk infants and children, which can decrease hospitalization and length of stay; also may be used for treatment in immunocompromised patients.
  • Beyfortus (Nirsevimab) – A preventive medication recommended by the CDC for babies before or during their first RSV season to help prevent severe RSV illness.
  • RSV Vaccine (Abrysvo – RSVpreF) – A vaccine approved for adults ages 60 and older and for pregnant people at 32-36 weeks of pregnancy to protect their newborn babies from RSV illness.
  • RSV Vaccine (Arexvy – RSVPreF3+AS01E) – A vaccine approved for adults ages 60 and older to protect against severe RSV disease.
  • RSV Vaccine (mRESVIA – mRNA-1345) – A vaccine approved for adults to protect against RSV infection.

Ongoing Clinical Trials on Respiratory syncytial virus infection

  • A Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease

    Recruiting

    Investigated diseases:
    Bulgaria Poland
  • Study of RSV vaccine immune response persistence and revaccination safety in adult lung and kidney transplant recipients

    Recruiting

    1 1 1
    Investigated diseases:
    Germany Italy Spain
  • Study of RSV vaccine and nirsevimab combination to prevent RSV infection in infants up to 12 months of age

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Belgium The Netherlands
  • Study on the Safety and Immune Response of rBCG-N-RSV Vaccine Compared to BCG Vaccine in Adults Over 60 with Respiratory Syncytial Virus (RSV) Concerns

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Greece
  • Study on the Safety and Tolerability of Sisunatovir in Infants and Children with RSV Infection

    Not yet recruiting

    Investigated diseases:
    Investigated drugs:
    Poland Spain
  • A study to evaluate the taste of sisunatovir and denatonium benzoate in healthy adults for the treatment of respiratory syncytial virus (RSV)

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Studying the Effect of Nirsevimab Immunization on Antibody Development After RSV Infection in Healthy Infants

    Not recruiting

    1 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on the Effectiveness and Safety of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Toddlers

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Finland Germany Spain
  • Study on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Poland Spain
  • Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18-49 at Risk for Respiratory Syncytial Virus Compared to Adults 60 and Older

    Not recruiting

    1 1 1 1
    Germany

References

https://www.mayoclinic.org/diseases-conditions/respiratory-syncytial-virus/symptoms-causes/syc-20353098

https://www.cdc.gov/rsv/about/index.html

https://www.nfid.org/infectious-disease/rsv/

https://medlineplus.gov/respiratorysyncytialvirusinfections.html

https://my.clevelandclinic.org/health/diseases/rsv-respiratory-syncytial-virus

https://www.health.ny.gov/diseases/communicable/respiratory_syncytial_virus/

https://www.dhs.wisconsin.gov/respiratory/rsv.htm

https://www.nhs.uk/conditions/respiratory-syncytial-virus-rsv/

https://www.mayoclinic.org/diseases-conditions/respiratory-syncytial-virus/diagnosis-treatment/drc-20353104

https://www.cdc.gov/rsv/symptoms/index.html

https://my.clevelandclinic.org/health/diseases/rsv-respiratory-syncytial-virus

https://pmc.ncbi.nlm.nih.gov/articles/PMC9961958/

https://pmc.ncbi.nlm.nih.gov/articles/PMC3461981/

https://www.chop.edu/news/health-tip/how-treat-rsv-home-and-when-go-doctor

https://emedicine.medscape.com/article/971488-treatment

https://www.lung.org/lung-health-diseases/lung-disease-lookup/rsv/treatment

https://medlineplus.gov/respiratorysyncytialvirusinfections.html

https://my.clevelandclinic.org/health/diseases/rsv-respiratory-syncytial-virus

https://www.mayoclinic.org/diseases-conditions/respiratory-syncytial-virus/symptoms-causes/syc-20353098

https://www.lung.org/lung-health-diseases/lung-disease-lookup/rsv/treatment

https://www.cdc.gov/rsv/causes/index.html

https://www.healthychildren.org/English/health-issues/conditions/chest-lungs/Pages/RSV-When-Its-More-Than-Just-a-Cold.aspx

https://medlineplus.gov/respiratorysyncytialvirusinfections.html

FAQ

Can adults get RSV or is it only a children’s disease?

Adults can absolutely get RSV, and it’s more common than many people think. While RSV is best known for affecting infants and young children, it infects people of all ages throughout their lives. In healthy adults, RSV usually causes mild, cold-like symptoms similar to a common cold. However, adults over 65, those with chronic heart or lung disease, and people with weakened immune systems are at higher risk for severe illness. Each year in the United States, RSV causes an estimated 100,000 to 160,000 hospitalizations among adults aged 60 and older.

How long does RSV last?

Most RSV infections resolve on their own within one to two weeks. Symptoms typically begin about four to six days after exposure to the virus and appear gradually over several days. People are usually contagious for three to eight days while symptoms are present, though some infants and immunocompromised individuals can remain contagious for up to four weeks. The cough, in particular, may persist for several days to several weeks even after other symptoms have improved, which is a normal part of recovery.

Is there a vaccine for RSV?

Yes, several RSV vaccines and preventive treatments are now available. For adults aged 60 and older, there are three approved RSV vaccines: Arexvy, Abrysvo, and mRESVIA. Pregnant people can receive the Abrysvo vaccine between 32 and 36 weeks of pregnancy to protect their newborn babies during their first six months of life. For infants, there’s a preventive medication called Beyfortus (Nirsevimab) recommended by the CDC for babies before or during their first RSV season. These immunizations represent significant advances in protecting vulnerable populations from severe RSV illness.

What’s the difference between RSV, a cold, and the flu?

RSV, common colds, and flu are all respiratory viruses that can cause similar symptoms, making them difficult to distinguish without laboratory testing. All three can cause runny nose, cough, sneezing, and fever. However, RSV is particularly dangerous for young infants and can cause severe lower respiratory tract infections like bronchiolitis and pneumonia, especially in babies under six months. The flu tends to cause more severe symptoms with higher fever and more body aches than typical colds. Because these illnesses look so similar, especially in adults and older children, healthcare providers may need to perform specific diagnostic tests to determine which virus is causing the illness.

When should I take my child to the emergency room for RSV?

Seek emergency medical care immediately if your child shows any of these warning signs: severe difficulty breathing, bluish or grayish color of the skin, lips or nails, skin pulling in between the ribs when breathing (called retractions), nostrils spreading out (flaring) when breathing, short, shallow or very fast breathing, pauses in breathing, extreme difficulty feeding or drinking, or appearing floppy and difficult to wake up. Also seek urgent care if your baby is under three months old with a fever of 38°C (100.4°F) or higher, if a child over three months has a fever of 39°C (102.2°F) or higher, or if your child shows signs of dehydration like having no wet diapers for 12 hours or more.

🎯 Key takeaways

  • Almost every child gets RSV before their second birthday, making it one of the most common childhood infections worldwide.
  • For most people, RSV feels like a bad cold that resolves within two weeks, but it can be life-threatening for babies under six months, older adults, and those with compromised immune systems.
  • New vaccines and preventive medications now exist to protect vulnerable populations, representing major breakthroughs after decades of research.
  • RSV can survive for many hours on hard surfaces like toys and doorknobs, making frequent cleaning and handwashing essential prevention strategies.
  • About 80% of infants hospitalized with RSV had no previously identified risk factors, meaning even seemingly healthy babies can become seriously ill.
  • There is no specific antiviral treatment that cures RSV—care focuses on managing symptoms and providing supportive treatment like oxygen and fluids.
  • People can spread RSV one to two days before they even develop symptoms, which is why the virus spreads so easily through families and childcare settings.
  • RSV causes approximately 58,000 to 80,000 hospitalizations in children under five years old each year in the United States alone.

Connected medications: